Development and pilot testing of a decision aid for postmenopausal women with osteoporosis

被引：88

作者：

Cranney, A

O'Connor, AM

Jacobsen, MJ

Tugwell, P

Adachi, JD

Ooi, DS

Waldegger, L

Goldstein, R

Wells, GA

机构：

[1] Ottawa Hosp, Dept Med, Ottawa, ON K1Y 4E9, Canada

[2] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada

[3] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada

[4] McMaster Univ, Dept Med, Hamilton, ON, Canada

[5] Ottawa Hosp, Dept Pathol & Lab Med, Ottawa, ON, Canada

来源：

PATIENT EDUCATION AND COUNSELING | 2002年 / 47卷 / 03期

关键词：

postmenopausal osteoporosis; therapies; decision support techniques; decision aid; patient education;

D O I：

10.1016/S0738-3991(01)00218-X

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

This study's aim was to develop and pilot test an evidence-based decision aid for postmenopausal women with osteoporosis who are considering options to prevent fractures. The aid was based on the Ottawa Decision Support Framework, and integrated evidence from our Cochrane systematic reviews. Following development by a panel of experts in osteoporosis and decision making, a user review panel of practitioners and women who had already made their decision about osteoporosis therapy reviewed the decision aid for acceptability. Then the decision aid was pilot tested using a before-after design in women at the point of decision making. Compared to baseline, there were statistically significant improvements in knowledge, realistic expectations and decreased decisional conflict. Our decision aid shows promise in preparing women for counseling about osteoporosis therapies. Long-term adherence to chosen therapy and quality of life will be evaluated in a randomized controlled trial. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：245 / 255

页数：11

共 25 条

[1] PATIENT REACTIONS TO A PROGRAM DESIGNED TO FACILITATE PATIENT PARTICIPATION IN TREATMENT DECISIONS FOR BENIGN PROSTATIC HYPERPLASIA [J].

BARRY, MJ ;

FOWLER, FJ ;

MULLEY, AG ;

HENDERSON, JV ;

WENNBERG, JE .

MEDICAL CARE, 1995, 33 (08) :771-782

[2]

BERNICK L, 2000, FRAMEWORK STRATEGY P, P1

[3]

BUNN H, 1996, CAN J NURS RES, V2, P813

[4]

Canadian Task Force on the Periodic Health Examination, 1994, CAN GUID CLIN PREV H

[5]

Cohen J., 1988, Statistical Power Analysisfor the Behavioral Sciences, V1, DOI DOI 10.1016/B978-0-12-179060-8.50006-2

[6] Patient-specific decisions about hormone replacement therapy in postmenopausal women [J].

Col, NF ;

Eckman, MH ;

Karas, RH ;

Pauker, SG ;

Goldberg, RJ ;

Ross, EM ;

Orr, RK ;

Wong, JB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (14) :1140-1147

[7] A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis [J].

Cranney, A ;

Guyatt, G ;

Krolicki, N ;

Welch, V ;

Griffith, L ;

Adachi, JD ;

Shea, B ;

Tugwell, P ;

Wells, G .

OSTEOPOROSIS INTERNATIONAL, 2001, 12 (02) :140-151

[8]

CRANNEY A, UNPUB ENDOCRINE REV

[9] RISK-FACTORS FOR HIP FRACTURE IN WHITE WOMEN [J].

CUMMINGS, SR ;

NEVITT, MC ;

BROWNER, WS ;

STONE, K ;

FOX, KM ;

ENSRUD, KE ;

CAULEY, JC ;

BLACK, D ;

VOGT, TM .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (12) :767-773

[10]

EDDY DM, 1998, OSTEOPOROS INT S4, V8, pS1

← 1 2 3 →